Lilly buys radiopharmaceutical startup Point Biopharma for $1.4B – Indianapolis Business Journal

Eli Lilly and Co. is paying Indianapolis-based startup Point Biopharma $12.50 a share, an 85% premium over the company’s closing price on Monday of $6.68 a share.

Related Keywords

Switzerland ,West Lafayette ,Indiana ,United States ,Indianapolis ,Joe Mccann ,Jacob Van Naarden ,Eli Lilly ,Therapeutics Acquisition Corp ,Point Biopharma Global Inc ,Endocyte Inc ,Point Biopharma ,Therapeutics Acquisition ,Georgetown Road ,